| BBIO Stock Yearly Return 2023 Table | ||||||||||||||||||||||||||||||
BBIO average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare BBIO average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| BBIO Share Performance |
| BBIO Stock Yearly Return 2023 Chart | |||
Also see: • BBIO YTD return • BBIO average annual return 10 years | |||
| About BridgeBio Pharma Inc |
| BridgeBio Pharma is a biopharmaceutical company to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Co.'s pipeline includes: Acoramidis (Eidos), which is an oral small molecule Transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Low-dose Infigratinib, which is an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-418, which is a small molecule substrate replacement therapy for the treatment of Limb Girdle Muscular Dystrophy Type 2I; and BBP-812, which is an adeno-associated virus gene therapy for the treatment of Canavan Disease. The BBIO stock yearly return is shown above.
The yearly return on the BBIO stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2023 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the BBIO annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| BBIO Current Stock Quote |
 Free BBIO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| BridgeBio Pharma (BBIO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
BBLG Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.
Video: Don't Forget Dividends in Average Annual Return!